Cooperative Agreement W58P052220012

The Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense awarded a $40.4 million cooperative agreement to Exela Pharma Sciences, LLC (Exela) to expand industrial base capabilities for COVID-19 response. With a period of performance from May 2022 through May 2034, this cooperative agreement will support Exela under the Research on Chemical and Biological Defense program (CFDA 12.360). Through this cooperative agreement, Exela will further the government's...

The University of Toledo was awarded a $6,831,000 Project Grant by the Department of Commerce National Institute of Standards and Technology under the Congressionally-Identified Projects program (CFDA 11.617). The grant will fund the expansion and renovation of the university's biosafety level 3 (BSL-3) and animal research facilities. Specifically, the project will double the size of the existing BSL-3 lab space by adding three new biocontainment suites capable of studying Tier 1 select agents...

This $15,083,516 federal Project Grant award, funded by the National Institutes of Health (NIH) under the Construction Support program (CFDA 93.352), will enable the modernization and renovation of the National Emerging Infectious Diseases Laboratories (NEIDL) at Boston University Medical Campus. The key objectives are to: 1) Modify the Biosafety Level (BSL)-3 and Animal Biosafety Level (ABSL)-3 spaces to improve decontamination and maintenance capabilities, 2) Renovate the Arthropod Containment...

This $1 million cooperative agreement from the National Science Foundation's Technology, Innovation, and Partnerships program aims to develop a microbial discovery and biosynthesis platform for targeted protease inhibitors to treat COVID-19. Think Bioscience, Inc. will expand its demonstrated approach using microbial systems to guide the discovery and assembly of protease inhibitors. The company will generate new intellectual property covering the discovery platform and promising small molecules...

This two-year, $512,200 Project Grant from the National Science Foundation's Biological Sciences program (CFDA 47.074) supports the development of a microbial "foundry" for distributed manufacturing of mRNA-containing biomaterials. Awarded on September 1, 2021 to Purdue University with a completion date of August 31, 2023, the grant will further the program's goals of advancing the biological sciences and strengthening the national scientific enterprise. Under this award, Purdue...

The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...

The Department of Transportation Federal Aviation Administration Northwest Mountain Region awarded a $15.1 million Project Grant to Spokane International Airport under the Airport Improvement Program, COVID-19 Airports Programs, and Infrastructure Investment and Jobs Act Programs (CFDA 20.106). The grant provides economic relief funding to prevent, prepare for, and respond to the COVID-19 pandemic through July 2025. Specifically, the funds will support costs related to airport operations,...

This Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084) provides $1,000,000 in funding to the Virginia Biotechnology Research Park Corporation (dba Activation Capital) to develop a robust pharmaceutical cluster program called the Alliance for Building Better Medicine in the Richmond/Petersburg region of Virginia. Over an 18-month period, the awardee will work with 23 core partners, including three direct...

The Economic Development Administration awarded Biobat, Inc. a $1.6 million Project Grant under the Economic Adjustment Assistance program (CFDA 11.307) on April 13, 2022. The funding will support Biobat's design and engineering costs to renovate approximately 24,515 square feet of vacant space at the Brooklyn Army Terminal building to provide expanded laboratory and office facilities for two biotechnology companies. The companies are working on products to treat coronavirus and had outgrown...

This Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems provides $500,000 to the Regents of the University of California at Riverside for research on rapid biomanufacturing of mRNA vaccines in plant chloroplasts. The award period is from January 1, 2022 to December 31, 2023. The research is funded under the NSF Directorate for Engineering's 47.041 CFDA program, which aims to improve quality of life and economic strength...